RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • Matrix Degrading enzymes of u-PA, PAI-1 and nm-23 Gene expression administering complex prescription of Huoxue Huayu

        Piao,Bingkui,Wang,Leyu,Bi,Zhenchun,Li,Gongshu,Cho,Chongkwan,Lin,Hongsheng INSTITUTE OF ORIENTAL MEDICINE KYUNG-HEE UNIVERSIT 1997 JOURNAL OF ORIENTAL MEDICINE Vol.2 No.1

        Background : The complex prescription of Huoxue Huayu is effective anti-metastasis drug for lung cancer by the clinic, and further basic experiments showed that it decreased the activity Urokinase-type plasminogen activator (u-PA) and increased the active of its inhibitor PAI-1 so as to impede matrix degradation and inhibit metastasis. In addition, nm23 gene has also been closely related to the course of carcinoma matastasis. Method: The trial involved 42 patients with stage I-III a lung carcinoma, 20 patients in the treated group, and 22 patients in the controlled group. All 20 patients in the treated group receives the complex prescription of Huoxue Huayu for 10 days preoperation. Using immunohistochemical assay, we observed u-PA, PAI-1 and nm23 expression in the tumor center, margin, stroma and normal lung tissue in lung carcinoma. Results : In the treated group, the uPA-positive rates in the center, margin and stroma of the tumor were 60%(12/20), 55%(11/20), and 20%(4/20) respectively The PAI-1-positive rates were 95%(19/20), 95%(19/20), and 65%(13/20) respectively. In the controlled group, the uPA-positive rates were 63.64%(14/22), 50%(11/22), 31.82%(7/22), and PaI-positive rates were 59.09%(13/22), 77.27%(17/22), and 59.10%(13/22) respectively in the same tumor site. The tumor nm23-positive rates in the controlled group were 45.45%(10/22); but in the treated group, the tumor nm23-positive rates were 65%(13/20). In the controlled group, the expression of u-PAI-1 in tumor and stroma of No was higher than u-PA; The expression of u-PA in N2 was higher than No; and the expression of PAI-1 in N2 was less than No. In LNM-patients, the expression of PAI-1 was high and u-P low. On the contrary, LNM+patients showed high expression of u-PA and low expression of PAI-1. In the treated group, the expression of the margin and strom a in No was higher than u-PA(P<0.01), the expression of u-PA weakened and PAI-1 enhanced, which, however, showed no significance compared with N2 of the controlled group of with NO of the treated group. The result suggested that the relationship of expression between N2 and No in the treated group differed from the controlled. In the controlled group, the positive expression of the nm23 gene was higher in LNM-patients than in LNM=. In the treated group, the positive rate of nm23 was higher in LNM-patients than in LNM+. In the treated group, the positive rate of nm23 was higher than the controlled group, whether LNM-or not. However in both groups the cases were few and statistical analysis was not different. Conclusion : In summary, the mechanism by which the prescription consisting mainly of Huoxue Huayu inhibits metastasis of lung carcinoma may be due to the impediment of enzyme degradation during metastasis.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼